{
    "title": "111_s1630",
    "content": "The Act may be cited as the \"Affordable Access to Prescription Medications Act of 2009\". Medicare Part D prescription drug plans are addressed in the Act. The \"Affordable Access to Prescription Medications Act of 2009\" amends Section 1860D-2(b)(4) of the Social Security Act to provide additional protections for co-payment or coinsurance requirements for prescription drug plans starting in 2011. The Affordable Access to Prescription Medications Act of 2009 amends Section 1860D-2(b)(4) of the Social Security Act to limit co-payment or coinsurance for covered part D drugs to $200 per month for a single drug and $500 per month for all drugs combined. These amounts will be adjusted annually based on the percentage increase or decrease in costs. The Affordable Access to Prescription Medications Act of 2009 amends Section 1860D-2(b)(4) of the Social Security Act to limit co-payment or coinsurance for covered part D drugs. Effective for plan years beginning on or after January 1, 2011, the Secretary shall expand the formulary tier exception request process for individuals enrolled in prescription drug plans. The Affordable Access to Prescription Medications Act of 2009 modifies the Social Security Act to allow individuals in prescription drug plans to request exceptions for specialty drugs. The Medicare Payment Advisory Commission will conduct a study on the prescription drug program under Medicare Part D. The Affordable Access to Prescription Medications Act of 2009 allows exceptions for specialty drugs in Medicare Part D plans, including an analysis of specialty tiers' impact on access to care for beneficiaries. The mechanisms described in the Act will be considered in the context of the Medicare part D anti-discrimination clause. The Act allows exceptions for specialty drugs in Medicare Part D plans, including specialty tiers, segmented coinsurance, and other benefit structures based on certain conditions for beneficiaries. The Medicare Payment Advisory Commission will submit a report to Congress within a year of the Act's enactment, detailing the study on utilization effects and recommendations for legislation. The Secretary will issue revised guidance on the use of mechanisms for prescription drug plans under Medicare Part D based on the study results. The Medicare Payment Advisory Commission will conduct a study on cost-sharing for prescription drugs under parts B and D of Medicare. The study will analyze the impact of eliminating cost-sharing for covered part D drugs for Medicare beneficiaries who exceed the initial coverage limit. The Medicare Payment Advisory Commission will conduct a study on cost-sharing for prescription drugs under parts B and D of Medicare. The study will analyze the impact of eliminating cost-sharing for covered part D drugs for Medicare beneficiaries who exceed the initial coverage limit. The Commission will submit a report to Congress with recommendations for legislation within 6 months of the Act's enactment. The curr_chunk provides definitions for terms related to Medicare Part D, including \"covered part D drug,\" \"MA-PD plan,\" \"Medicare Advantage organization,\" and \"PDP sponsor.\" The curr_chunk defines \"PDP sponsor\" and \"prescription drug plan\" in relation to Medicare Part D. SEC. 3. PRIVATE HEALTH INSURANCE. Amends the Public Health Service Act to include provisions relating to prescription drugs in group health plans. Group health plans and health insurance issuers offering coverage for prescription drugs must ensure that co-payment or coinsurance requirements do not exceed certain limits set by the Secretary. This includes not exceeding the base cost of the drug, $200 per month for a single prescription drug, and $500 per month for all prescription drugs combined. Adjustments to these limits are made annually based on the Consumer Price Index. The Consumer Price Index determines the annual adjustments for co-payment limits on prescription drugs in group health plans. Compliance with notice requirements under the Employee Retirement Income Security Act is necessary. Amendments to ERISA include adding sections 2708 to the Act. The Employee Retirement Income Security Act of 1974 is amended by adding a new section to Title I. The Employee Retirement Income Security Act of 1974 is amended by adding a new section to Title I, which includes provisions relating to prescription drugs. The Employee Retirement Income Security Act of 1974 is amended to include provisions regarding group health plans and health insurance issuers offering coverage for prescription drugs. Co-payment or coinsurance requirements for prescription drugs must not exceed specified limits, with adjustments made annually. The Employee Retirement Income Security Act of 1974 is amended to include provisions for group health plans and health insurance issuers offering prescription drug coverage. Co-payment or coinsurance limits for prescription drugs must be adjusted annually based on the Consumer Price Index. Group health plans must comply with notice requirements under section 714(b). The Employee Retirement Income Security Act of 1974 is amended to include provisions for group health plans and health insurance issuers offering prescription drug coverage. Co-payment or coinsurance limits for prescription drugs must be adjusted annually based on the Consumer Price Index. Group health plans must comply with notice requirements under section 714(b). Additionally, Section 715 introduces provisions relating to prescription drugs in the Internal Revenue Code of 1986. Group health plans and health insurance issuers offering prescription drug coverage must ensure that co-payment or coinsurance requirements for prescription drugs do not exceed certain limits: $200 per month for a single prescription drug and $500 per month for all prescription drugs combined. These limits are subject to annual adjustments based on the Consumer Price Index. The co-payment and coinsurance limits for prescription drugs in group health plans and insurance issuers are annually adjusted based on the Consumer Price Index. Plans must also comply with notice requirements under the Employee Retirement Income Security Act of 1974. The provisions relating to prescription drugs in individual health insurance plans are amended to align with those in group health plans. These changes also apply to the Federal Employees Health Benefits Program."
}